Andre Goy, M.D., chairman, John Theurer Cancer Center at Hackensack University Medical Center, was featured in a recent OncLive webinar. The webinar focused on treatment options for Relapsed/Refractory Diffuse Large B-Cell Lymphoma as well as DLBCL Risk Assessment and Genetic Signatures.
The webinar is now available and can be viewed by clicking here.
Some key topics discussed in the webinar, include:
- Risk assessment for DLBCL and what prognostic factors are most important
- How cardiovascular and CNS comorbidities influence treatment
- Discussing for which patients is transplant an option and what options there are for patients who are not eligible for transplant?
- CD19-targeted CAR-T therapies and what issues or concerns have been seen with these therapies